Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2011

Sep 14, 2011

29777_dirs_2011-09-14_4ffa1542-91da-4522-b48b-7245c1b026c0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2011-09-12

Reporting Person: Fussell Stephen R (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-09-12 Common shares without par value M 450 $44.16 Acquired 576 Indirect
2011-09-12 Common shares without par value S 450 $49.872 Disposed 126 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-09-12 Option (right to buy) $44.16 M 450 Disposed 2011-09-13 Common shares (450) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 87166 Direct
Common shares without par value 954 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of Sepember 12, 2011.

F2: The reporting person disclaims beneficial ownership of all securities held by his spouse.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.